AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05855694 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: THOR LED Photobiomodulation Helmet - Therapeutic
Description: Photobiomodulation (PBM) is a non-invasive treatment option that uses nonionizing light sources such as laser diodes and light-emitting diodes in the visible and near-infrared spectrum.~Each participant will be required to sit with the helmet device over their head for the length of their study session. Participants and study staff will wear protective goggles throughout each session. These goggles help to block out any red LED light emitted from the helmet device. Participants may experience a pleasant warmth upon their head during both the therapeutic and control settings.~Helmet will be in 'therapeutic setting' of 35mW/cm2 = 42J/cm2
Study NCT05855694 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: THOR LED Photobiomodulation Helmet - Control
Description: Each participant will be required to sit with the helmet device over their head for the length of their study session. Participants and study staff will wear protective goggles throughout each session. These goggles help to block out any red LED light emitted from the helmet device. Participants may experience a pleasant warmth upon their head during both the therapeutic and control settings.~Helmet will be in 'non-therapeutic setting' of 0mW/cm2 = 0J/cm2
Study NCT06691945 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Saline delivered using an intrauterine pressure catheter (IUPC)
Description: An intrauterine pressure catheter (IUPC) will be placed in participants after membrane rupture, or at 4 cm if membranes previously ruptured. A 300cc bolus of normal saline will be administered. A continuous rate of 100 cc/hr of normal saline will continue until delivery to prevent Postpartum Hemorrhage. If the IUPC is dislodged, it will be replaced by a trained clinician.
Study NCT06726018 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conditioned Pain Modulation (CPM)
Description: Participants will receive a testing stimulus of pressure applied per ascending intensity at the web space of the foot until the pain reaches 40 out of 100, then discontinued. After testing the stimulus, participants will then receive a conditioning stimulus by immersing the non-dominant hand into the water-cooled by refrigeration unit with a temperature of 6 degree Celsius (males) or 8 degree Celsius (females) for 60 seconds. Subjects will be asked to rate the cold pain during the four 60-second trials. Participants completely removed their hand from the cold pressor for 30 seconds following each of the four 60-second immersions, during which time the testing stimulus will be re-applied per the sequential paradigm to the web space of the foot. Participants complete four 60-second periods of immersion.
Study NCT05220891 — intervention group
Intervention type: OTHER
Intervention: Paracentesis
Description: Paracentesis from ascitic patient
Study NCT06344247 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RAS inhibitors：Losartan®️/Valsartan®️
Description: Losartan®️/Valsartan®️ : maintain the maximum dose/maximum tolerated dose.
Study NCT06726018 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conditioned Pain Modulation (CPM)
Description: Participants will receive a testing stimulus of pressure applied per ascending intensity at the web space of the foot until the pain reaches 40 out of 100, then discontinued. After testing the stimulus, participants will then receive a conditioning stimulus by immersing the non-dominant hand into the water-cooled by refrigeration unit with a temperature of 6 degree Celsius (males) or 8 degree Celsius (females) for 60 seconds. Subjects will be asked to rate the cold pain during the four 60-second trials. Participants completely removed their hand from the cold pressor for 30 seconds following each of the four 60-second immersions, during which time the testing stimulus will be re-applied per the sequential paradigm to the web space of the foot. Participants complete four 60-second periods of immersion.
Study NCT05934578 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise training
Description: Aerobic and light muscle resistance exercise by online cardiovascular rehabilitation
Study NCT06344247 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dapagliflozin：Forxiga®️
Description: Forxiga®️ : titrated to the target dose (10 mg qd).
Study NCT06746584 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: benson relaxation exercise
Description: BRT is one of the behavioural intervention techniques developed by Herbert Benson in 1975. BRT is based on the principle of deep breathing and relaxing all the muscles in the body by choosing a word that is meaningful for the individual and focusing on it. This exercise, which has no side effects on patients and can be applied for patients of all age groups, is more widely used because it is a simple and easy-to-learn method compared to other relaxation methods all the muscles in the body by choosing a word that is meaningful for the individual and focusing on it.
Study NCT06746415 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Gait Training
Description: onventional walking training group will be given 20 minutes of NMES, 20 minutes of weight transfer, stretching, mobilization, bobath exercises and 20 minutes of parallel bar walking exercises. Patients in both groups will be treated 3 days a week, 1 hour a day for 6 weeks.
Study NCT06746415 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Robotic Gait Training
Description: The robot-assisted walking group will receive 20 minutes of NMES, 20 minutes of weight transfer, stretching,mobilization, bobath exercises and 20 minutes of robot-assisted walking exercises. Patients in both groups will be treated 3 days a week, 1 hour a day for 6 weeks
Study NCT05642988 — intervention group
Intervention type: DEVICE
Intervention: LifeSignals 1AX Biosensor
Description: Biosensor worn by patients for 30-days after intra-abdominal or pelvic surgery on discharge from hospital
Study NCT05132634 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hand Massage
Description: Like a massage, the superficial kneading technique which is included in the Swedish massage technique will be applied in a way to create a slight pressure on the patient, and it will be terminated again with the effleurage technique. The procedure was concluded in a way that each massage technique was applied and the massage was for a total of 15-20 minutes.
Study NCT04740359 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional training
Description: The therapy program was planned for 8 weeks and the sessions were performed in 45 minutes (min) for 3 days a week. The functional reach (forward-lateral-cross), trunk rotation exercises were performed in the sitting positions.(25min) Facilitation of trunk extension and elongation in the prone position (10 min). Thoracic mobilization on exercise ball (10min).
Study NCT04740359 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine training
Description: The therapy program was planned for 8 weeks and the sessions were performed in 45 minutes (min) for 3 days a week. The strengthening exercises were applied on the mat (3x10 for the first 4 weeks and 3x15 repetition for the last 4 weeks). Eyes open-closed perturbation training was performed for trunk control in sitting and standing positions (10 min.).
Study NCT05406362 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VAD044
Description: capsules to be taken once daily for 12 weeks
Study NCT05406362 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: VAD044
Description: capsules to be taken once daily for 12 weeks
Study NCT06220058 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Closure of the midline laparotomy using the small bites technique
Description: Closure of the midline laparotomy using the small bites technique will involve employing a monofilament polydioxanone suture with a gauge of 0 (PDS® II Ethicon, Bridgewater, NJ). No Redon drainage system will be left in the subcutaneous tissue.
Study NCT05649566 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality game
Description: The game consists of cutting mobile targets, using lightsabers while avoiding obstacles that approach the user. This game is a reference for immersive play since, while distracting, it recreates a physical activity similar to what would be done in reality. It has been shown that the same energy expenditure, on the part of the user, practicing tennis in real life, is what he does playing Beat Saber playing the same period of time.
Study NCT06220058 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Closure of the midline laparotomy using the small bites technique with an absorbable PP mesh
Description: Closure of the midline laparotomy using the small bites technique will involve employing a monofilament polydioxanone suture with a gauge of 0 (PDS® II Ethicon, Bridgewater, NJ). A partially absorbable low-density polypropylene suprapubic mesh (Ultrapro®, Ethicon) will be added. Mesh fixation will be done with absorbable staples (Ethicon SecurestrapTM) +/- slow-absorbing resorbable sutures at the discretion of the surgical team.~In the case of a diverting stoma, the prophylactic mesh will not encircle it. A Redon-type drainage will be left at the subcutaneous tissue level. One or two drains will be left at the discretion of the surgical team. Closure of the subcutaneous tissue will be performed with 2/0 or 3/0 absorbable, multifilament, interlocking sutures.
Study NCT04853030 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fiasp
Description: Advanced closed-loop insulin therapy with Faster acting insulin Aspart (Fiasp)
Study NCT05091593 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stepped collaborative care intervention
Description: Using website that was specifically designed for advanced cancer patient, collaborative with treatment from health professional.
Study NCT05091593 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care
Description: Usual care from health providers
Study NCT06746792 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low-load resistance exercise with blood flow restriction
Description: BFR-RE group performed bilateral leg extension exercises to volitional exhaustion (90 seconds rest between sets, 30% 1RM) with BFR cuffs applied at 60% of limb occlusion pressure.
Study NCT04853030 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Novorapid
Description: Advanced closed-loop insulin therapy with Standard acting insulin Aspart (Novorapid
Study NCT06203093 — intervention group
Intervention type: OTHER
Intervention: Biological Sample Collection
Description: Skin biopsy (2-3mm) and/or blood (up to 50mL); saliva; excess/leftover biospecimens that were (or will be) collected for other purposes (e.g., medical procedure).
Study NCT06344247 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simagliptin：Forxiga®️
Description: Semaglutide®️ : titrated to the target dose (1 mg qw).
Study NCT04132297 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Asthma Academy
Description: The Asthma Academy is a one hour virtual training that includes providing information about asthma, asthma medications, communicating with healthcare providers and navigating healthcare resources.
Study NCT04132297 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telehealth Visit
Description: The telehealth Visit will be conduct by a trained Doctor of Nurse Practice (DNP) student via a scheduled meeting through zoom on the participant's smart phone or computer. The visit will last about one hour wherein participant will be asked about their asthma knowledge and will be given information about asthma.
Study NCT06158152 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: AM3 + Probiotic
Description: Two capsules daily in the morning during 12 weeks. The capsule contains the mixture of AM3 Technology and probiotic SynBalance Metsyn.
Study NCT06158152 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Two capsules daily in the morning during 12 weeks. The capsule contains starch.
Study NCT06158152 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: SHAM_COMPARATOR
Intervention: AM3
Description: Two capsules daily in the morning during 12 weeks. The capsule contains AM3 Technology.
Study NCT05401916 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tramadol
Description: Patients will be received tramadol with intravenous patient controlled analgesia (IV PCA) device during postoperative 24 hours. The PCA solution will be prepared with 500 mg tramadol in 100 mL of saline (5 mg/ml). The PCA device was adjusted as infusion: 2 ml/h, bolus: 2 ml, lockout period: 15 min.
Study NCT05401916 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paracetamol
Description: 1 g paracetamol will be administered 30 minutes before the end of surgery. All administrations will be applied through IV infusion over 30 minutes. Patients will be received tramadol with intravenous patient controlled analgesia (IV PCA) device during postoperative 24 hours. The PCA solution will be prepared with 500 mg tramadol in 100 mL of saline (5 mg/ml). The PCA device was adjusted as infusion: 2 ml/h, bolus: 2 ml, lockout period: 15 min.
Study NCT05401916 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen
Description: 800 mg ibuprofen (diluted with 250 ml saline) will be administered 30 minutes before the end of surgery. All administrations will be applied through IV infusion over 30 minutes. Patients will be received tramadol with intravenous patient controlled analgesia (IV PCA) device during postoperative 24 hours. The PCA solution will be prepared with 500 mg tramadol in 100 mL of saline (5 mg/ml). The PCA device was adjusted as infusion: 2 ml/h, bolus: 2 ml, lockout period: 15 min.
Study NCT06746792 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-load resistance exercise
Description: The HL-RE group performed the same exercise to volitional exhaustion (90 seconds rest between sets, 70% 1RM) without BFR cuffs.
Study NCT06402305 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Lipid profile
Description: Abdominal ultrasound and lipid profile will be done
Study NCT06745960 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: electrical muscle stimulation device (EMS gymna)
Description: muscle stimulant device
Study NCT06745960 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: physical therapy program
Description: neck exercises
Study NCT06745960 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: physical therapy program
Description: neck exercises
Study NCT06747559 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin D
Description: Vitamin D oral supplementation
Study NCT06746805 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: CHO+KETONE
Description: Sports drink containing glucose and ketone mono-esters
Study NCT06746805 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: CHO+PLACEBO
Description: Sports drink containing glucose and placebo
Study NCT06747429 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High fat diet
Description: Weekly isocaloric dietary profile, with total daily energy intake distributed as follows: 70% from fats, primarily sourced from nuts, extra virgin olive oil, avocados, and animal fats from fish and cheese; protein intake of 0.8-1.2 g per kg body weight (10-20%); and the remaining calories from carbohydrates (10-20%).
Study NCT06747429 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard diet
Description: Weekly isocaloric dietary profile, with total daily energy intake distributed as follows: 30% from fats, primarily sourced from nuts, extra virgin olive oil, avocados, and animal fats from fish and cheese; protein intake of 0.8-1.2 g per kg body weight (10-20%); and 50-60% from carbohydrates.
Study NCT06548334 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Advanced Physiotherapy
Description: The physiotherapist used the regression techniques for 1 hour of session 2 times for 8 weeks. The caudal component involved the spinous process of the treated segment touching the therapist's hand and not applying force as though mobilising the segment at grade 2. These were applied if there is a suspected case of a posterolateral disc prolapse where the aim is to increase the diameter of the foramen and decrease the tension exerted on the nerve root. Applied posteroanterior was used to distract the anterior intervertebral end plate and to approximate the posterior end plates so as to pull back the protruded nuclear material by creating a negative pressure.
Study NCT06548334 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physiotherapy Techniques
Description: In traditional physiotherapy, the patient underwent two sessions per week for eight weeks. Each session lasted one hour and included 20minutes of TENS treatment. The flexibility exercises consisted of hamstring stretches and single and double knee-to-chest stretches. The strengthening exercises were partial sit-ups, quadruped lifts, and double leg hold; pelvic tilts were performed with 10-15 repetitions, each held for 20-30 seconds and repeated three times.
Study NCT06746558 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Potassium Nitrate Gel and Diode Laser Therapy
Description: Participants in the experimental group receive treatment combining a desensitizing gel containing 5% potassium nitrate (Emoform Actisens) applied to affected teeth and diode laser therapy (980 nm). The laser is used with specific power settings (0.3W, 0.5W, 0.7W) for 20 seconds at each setting, followed by a second application of the gel and irradiation. The treatment aims to reduce dentinal hypersensitivity by occluding dentinal tubules and altering neural responses.
Study NCT06746558 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Potassium Nitrate Gel Alone
Description: Participants in the control group receive treatment with a desensitizing gel containing 5% potassium nitrate (Emoform Actisens) applied to the teeth. The gel is applied twice using a microbrush in a rubbing motion for 2 minutes each time. No diode laser therapy is administered. This intervention aims to evaluate the standalone efficacy of the gel in reducing dentinal hypersensitivity.
Study NCT06249633 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitric Oxide
Description: Inhaled nitric oxide
Study NCT05781360 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SIM0237
Description: SIM0237 should be administered intravenously at recommended dose qw or other dosing regimens
Study NCT05461924 — intervention group
Intervention type: OTHER
Intervention: questionnaire survey
Description: questionnaire survey the long term outcomes of long-segment HSCR and compared with rectosigmoid HSCR
Study NCT06477419 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sacituzumab govitecan-hziy
Description: After enrollment, participants will receive SG until disease progression or intolerable toxicity.
Study NCT05395351 — intervention group
Intervention type: DRUG
Intervention: rt-PA
Description: Intravenous recombinant tissue plasminogen activator (IV rt-PA)
Study NCT05065437 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active (Virtual reality and spinal stimulation)
Description: Each session is 25 minutes; 5 minutes of setup, and 20 minutes of simultaneous spinal stimulation at the cervical level and immersive virtual experience/gameplay.
Study NCT05663372 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efez 50 mg eplerenone film-coated tablets
Description: Oral, mineralocorticoid receptor antagonist, a blocker of aldosterone
Study NCT05663372 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: INSPRA® 50 mg eplerenone film-coated tablets
Description: Oral, mineralocorticoid receptor antagonist, a blocker of aldosterone
Study NCT04823819 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Magnetic Stimulator DuoMag
Description: Stimulation of the left dorsolateral prefrontal cortex
Study NCT04823819 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Stimulator DuoMag
Description: Stimulation of the left dorsolateral prefrontal cortex
Study NCT04823819 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: neuroConn DC-STIMULATOR
Description: One electrode (anode) will be placed on the left dorsolateral prefrontal cortex, the other (cathode) on the right temporal lobe.
Study NCT04823819 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: neuroConn DC-STIMULATOR
Description: One electrode (anode) will be placed on the left dorsolateral prefrontal cortex, the other (cathode) on the right temporal lobe.
Study NCT05234216 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Informed consent
Description: the investigator will verify the inclusion criteria, the patient's understanding of the protocol and will obtain oral informed consent
Study NCT05234216 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Informed consent
Description: the investigator will verify the inclusion criteria, the patient's understanding of the protocol and will obtain oral informed consent
Study NCT05234216 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery
Description: The patient will undergo surgery in accordance with standard care
Study NCT05234216 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Surgery
Description: The patient will undergo surgery in accordance with standard care
Study NCT05234216 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Comfort scale
Description: The patient will be evaluated, in the post-operative care unit, with a comfort scale
Study NCT05234216 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Pain
Description: The patient will be evaluated, in the post-operative care unit, with a pain scale
Study NCT05234216 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Evaluation of the Experience of Local/General Anesthesia